ATRA compared with ZYME: revenue, margins and what each company keeps, and the suppliers and customers both name

ATRAAtara Biotherapeutics, Inc.

Mkt capRevenueRevenue

ZYMEZymeworks Inc.

Mkt capRevenueRevenue

Compare

ATRAAtara Biotherapeutics, Inc.

ZYMEZymeworks Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ATRA 5

—FUJIFILM Diosynth Biotechnologies California, Inc. (FDB)unlistedsupplier

—Memorial Sloan Kettering Cancer Center (MSK)unlistedsupplier

—QIMR Berghoferunlistedsupplier

—HCR Molag Fund L.P. (HCRx)unlistedcustomer

1 more · ATRA chain ›

Shared 0

No shared counterparties.

Only ZYME 11

JNJJ&Jcustomer

BMYCelgene (now BMS)customer

JAZZJazz Pharmaceuticals Irelandcustomer

RPRXRoyalty Pharmacustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

7 more · ZYME chain ›

ATRAAtara Biotherapeutics, Inc.

8.47▲+5.68%· post 8.41· delayed

Mkt cap$80.4MRevenue$630,000Q2 FY26Revenue$121MFY25

ZYMEZymeworks Inc.

28.99▲+1.33%· post 28.99· delayed

After hoursNov 2 '26delayed

Mkt cap$2.1BRevenue$5MQ2 FY26Revenue$106MFY25

Compare

After hoursNov 2 '26delayed

ATRAAtara Biotherapeutics, Inc.

ZYMEZymeworks Inc.

8.47▲+5.68%post 8.41delayed

Price

28.99▲+1.33%post 28.99delayed

$80.4M

Mkt cap

$2.1B

Q2 FY26$630,000

Revenue

$5MQ2 FY26

FY25$121M

Revenue

$106MFY25

ATRA8.47▲+5.68%vsZYME28.99▲+1.33%After hoursNov 2 '26delayed